Adverse Overall Survival Impact of PD-L1 Positivity in Patients With KRAS G12C Mutation Is Abolished by the Immunotherapy.

Clin Lung Cancer

Department of Pathology and Laboratory Medicine, AdventHealth Orlando, Orlando, FL. Electronic address:

Published: November 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2021.04.010DOI Listing

Publication Analysis

Top Keywords

adverse survival
4
survival impact
4
impact pd-l1
4
pd-l1 positivity
4
positivity patients
4
patients kras
4
kras g12c
4
g12c mutation
4
mutation abolished
4
abolished immunotherapy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!